CD4 and schizophrenia: Motivated by the evidence for dopaminergic signalling in the CNS as a key mechanism for pathogenesis and pharmacological treatment of schizophrenia, we tested the mechanistic hypothesis that dopamine receptor expression may also be altered in separated CD4+ T-cells, and that this may be correlated with observed alterations in T-cell subpopulations.